AI4MEDIMAGING
AI4MedImaging developed an AI-based software that performs a fully automatic segmentation of both ventricles and an automatic identification of cardiac patients with normal wall motion.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
N/A | Support Program | ||
| Total Funding | 000k | ||
| EUR | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
AI4MedImaging is a Portugal-based startup that specializes in applying artificial intelligence (AI) to medical imaging, with a particular focus on cardiac magnetic resonance imaging (MRI). The company addresses a critical need in the medical field by developing AI models that assist in the segmentation of cardiac chambers and the interpretation of left ventricle wall motion. This technology aims to improve workflow efficiency, enhance patient outcomes, and meet unmet medical needs in cardiac imaging.
AI4MedImaging primarily serves healthcare providers, including hospitals and diagnostic imaging centers, that require advanced imaging solutions to improve their cardiac diagnostic processes. The company operates in the medical imaging market, which is a growing sector driven by the increasing prevalence of cardiovascular diseases and the need for more accurate and efficient diagnostic tools.
The business model of AI4MedImaging revolves around the development and commercialization of AI-powered software solutions. Their flagship product, AI4CMR, has received CE Mark certification, which is a significant milestone indicating compliance with European health, safety, and environmental protection standards. This certification allows the company to market and sell its software across Europe.
AI4MedImaging generates revenue by licensing its AI software to healthcare providers. The software helps these providers reduce time spent on manual image analysis, increase patient throughput, and boost overall productivity. By offering a subscription-based model or one-time licensing fees, AI4MedImaging ensures a steady stream of income while providing valuable tools to its clients.
In summary, AI4MedImaging is a pioneering company in the field of AI-driven cardiac imaging solutions. With a strong team experienced in AI and cardiac imaging, the company is well-positioned to transform the landscape of medical imaging.
Keywords: AI, medical imaging, cardiac MRI, healthcare, software, CE Mark, diagnostics, workflow efficiency, patient outcomes, Portugal.